10 posts with this tag
Safety and Toxicity of Small Molecule Inhibitors in Dogs with Spontaneously Occurring Malignancies — The Use of Real World Data
The VCS Virtual Conference was held from October 15 - 17, 2020. We had the honor of presenting our abstract during the event.
Why is the Palladia dose used at the clinic often different from the one on the FDA-approved label? Over 100 human targeted therapies have been approved, yet many doses were found to be incorrect in the post market stage. Why is that?Data
In human oncology, there has been a growing focus on analyzing data gathered from routine care, leading to a new field called real world evidence (RWE), which has taken off in recent years. The RWE approaches being used in human oncology can also be applied in the veterinary space.
One of the first pets to be enrolled in FidoCure®, Forrest, a 11 year-old Golden Retriever diagnosed with hemophagocytic histiocytic sarcoma, illustrates the value of evaluation of exceptional responders.Data
In the wake of the COVID-19 pandemic, there has been an uptick in demand for at-home oral targeted therapies. With it, came increased interest in the side effect profile of these therapies.